This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the creation of various drug candidates, especially those targeting neurological disorders and infectious diseases. Its structure, featuring a fluoropyridine moiety, is valuable for enhancing the bioavailability and metabolic stability of potential drugs. Additionally, it is employed in the development of small molecule inhibitors and modulators for specific biological targets, contributing to advancements in medicinal chemistry and drug discovery.